MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.

Detsky JS, Chan AW, Moore-Palhares D, Safavi AH, Perry J, Fat MJL, Atenafu EG, Das S, Lipsman N, Heyn C, Maralani P, Czarnota GJ, Ruschin M, Keller B, Lau A, Chen H, Myrehaug SD, Soliman H, Tseng CL, Sahgal A.

Open source

DOI
10.1016/s1470-2045(26)00088-4
Published
2026-05-14
Container
Lancet Oncol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00088-4,
  title = {MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.},
  author = {Detsky JS and  Chan AW and  Moore-Palhares D and  Safavi AH and  Perry J and  Fat MJL and  Atenafu EG and  Das S and  Lipsman N and  Heyn C and  Maralani P and  Czarnota GJ and  Ruschin M and  Keller B and  Lau A and  Chen H and  Myrehaug SD and  Soliman H and  Tseng CL and  Sahgal A.},
  year = {2026},
  journal = {Lancet Oncol},
  doi = {10.1016/s1470-2045(26)00088-4},
  url = {https://doi.org/10.1016/s1470-2045(26)00088-4}
}

RIS

TY  - JOUR
TI  - MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.
AU  - Detsky JS
AU  -  Chan AW
AU  -  Moore-Palhares D
AU  -  Safavi AH
AU  -  Perry J
AU  -  Fat MJL
AU  -  Atenafu EG
AU  -  Das S
AU  -  Lipsman N
AU  -  Heyn C
AU  -  Maralani P
AU  -  Czarnota GJ
AU  -  Ruschin M
AU  -  Keller B
AU  -  Lau A
AU  -  Chen H
AU  -  Myrehaug SD
AU  -  Soliman H
AU  -  Tseng CL
AU  -  Sahgal A.
PY  - 2026
JO  - Lancet Oncol
DO  - 10.1016/s1470-2045(26)00088-4
UR  - https://doi.org/10.1016/s1470-2045(26)00088-4
ER  - 

APA

JS, D., AW, C., D, M., AH, S., J, P., MJL, F., EG, A., S, D., N, L., C, H., P, M., GJ, C., M, R., B, K., A, L., H, C., SD, M., H, S., CL, T., & A., S. (2026). MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.. Lancet Oncol. https://doi.org/10.1016/s1470-2045(26)00088-4

Source records